Iloprost for chronic thromboembolic pulmonary hypertension;Iloprost en la hipertensión pulmonar tromboembólica crónica

Archivos de Bronconeumologia

Volumn 40, Issue 7, 2004, Pages 326-328

  Roig Figueroa, V ^a,b   Herrero Perez A ^a   De La Torre Ferrera, N ^a   Hernandez Garcia E ^a   Aller Alvarez, J L ^a   Para Cabello, J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b NONE   (Spain)

Author keywords

Chronic thromboembolic pulmonary hypertension; Iloprost; Thromboendarterectomy

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ILOPROST; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

AGED; ARTICLE; CASE REPORT; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL FEATURE; DRUG MECHANISM; ENDARTERECTOMY; FEMALE; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; MALE; PULMONARY HYPERTENSION; SAFETY; SURGICAL RISK; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 3142780143     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13063228     Document Type: Article

References (15)

1. Fedullo PF, Auger WR, Kera KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
2. Jamieson SW, Kapelanski DP. Pulmonary endarterecyomy. Curr Probl Surg 2000;37:165-252.
3. Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001;22:561-81.
4. Kramm T, Mayer E, Dahm M, Guth S, Menzel T, Pitton M, et al. Long-term results after thromboendarterectomy for chronic pulmonary embolism. Eur J Cardiothoracic Surg 1999;15:579-83.
5. Bradley SP, Auger WR, Moser KM. Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol 1996;78:584-7.
6. Olchewsky H, Simmoneau G, Galié N, Higenbottam T, Naeije R, Rubin LJ, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-9.
7. Rubin LJ, Badesc DB, Barst RJ, Galié N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
8. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotany S, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-43.
9. Ono F, Nagaya N, Okumura H, Shimizu Y, Kyotani S, Nakanishi N, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003;123:1583-8.
10. Ghofrani HA, Wiedemann R, Rose F, Olchewsky H, Schemuly RT, Weissmann N, et al. Combination therapy with oral sildenafil and inhaled lloprost for severe pulmonary hypertension. Ann Intern Med 2002;136:515-22.
11. Webb SA, Stott S, Van Heerden PV. The use of inhaled aerosolized prostacyclin in the treatment of pulmonary hypertension secundary to pulmonary embolism. Intensive Care Med 1996;22:353-5.
12. Gómez Sánchez MA, Lázaro Salvador M, Escribano Subias P, Delgado Jiménez JF, Tello de Meneses R, Cea Calvo I, et al. Nuevos tratamientos médicos en la hipertensión pulmonar. Arch Bronconeumol 2002;38(Supl 1):29-32.
13. Wilkens H, Bauer M, Forestier N, Konig J, Eichler A, Schneider S, et al. Influence of inhaled iloprost transpulmonary gradient of big endothelin patients with pulmonary hypertension. Circulation 2003;107:1509-23.
14. Optiz CF, Wensel R, Bettmann M, Schaffarzyk R, Linscheid M, Hetzer R, et al. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administred by either infusion or inhalation. Eur Heart J 2003;24:356-65.
15. Barberá JA. Nueva nomenclatura y clasificación de la hipertensión pulmonar. Arch Bronconeumol 2002;38(Supl 1):3-9.